A round up of all the latest news on www.globaluniversityventuring.com for our subscribers.
Big deal: NMD series A muscles
Aarhus University spinout NMD Pharma, which focuses on therapies for neuromuscular conditions, has attracted the support of several corporates for its $47m series A round.
The Johns Hopkins spinout will funnel the cash into developing a class of glutamine antagonist that could help treat cancer.
Renephra lances $327,000 round
The transdermal fluid removal spinout will aim for a close of…
